780240

Fougera Pharmaceuticals Inc. — FEI 2432435

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 15, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Melville, NY (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)